|An update on pharmacological potential of boswellic acids against chronic diseases|
NK Roy, D Parama, K Banik, D Bordoloi, AK Devi, KK Thakur, ...
International journal of molecular sciences 20 (17), 4101, 2019
|Targeting AKT/mTOR in oral cancer: Mechanisms and advances in clinical trials|
C Harsha, K Banik, HL Ang, S Girisa, R Vikkurthi, D Parama, V Rana, ...
International journal of molecular sciences 21 (9), 3285, 2020
|Direct electrochemical reduction of hematite decorated graphene oxide (α-Fe2O3@ erGO) nanocomposite for selective detection of Parkinson's disease biomarker|
G Mathew, P Dey, R Das, SD Chowdhury, MP Das, P Veluswamy, ...
Biosensors and Bioelectronics 115, 53-60, 2018
|Inflammation, NF-κB, and chronic diseases: how are they linked?|
AB Kunnumakkara, B Shabnam, S Girisa, C Harsha, K Banik, TB Devi, ...
Critical Reviews™ in Immunology 40 (1), 2020
|Diosgenin, a steroidal saponin, and its analogues: Effective therapies against different chronic diseases|
D Parama, M Boruah, Y Kumari, V Rana, K Banik, C Harsha, KK Thakur, ...
Life sciences, 118182, 2020
|COVID-19, cytokines, inflammation, and spices: How are they related?|
AB Kunnumakkara, V Rana, D Parama, K Banik, S Girisa, H Sahu, ...
Life sciences, 119201, 2021
|Rationalizing the therapeutic potential of apigenin against cancer|
SA Ahmed, D Parama, E Daimari, S Girisa, K Banik, C Harsha, U Dutta, ...
Life Sciences, 118814, 2020
|Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases|
UD Daimary, D Parama, V Rana, K Banik, A Kumar, C Harsha, ...
Current Research in Pharmacology and Drug Discovery, 100008, 2020
|Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer|
S Girisa, D Parama, C Harsha, K Banik, AB Kunnumakkara
Exploration of Targeted Anti-tumor Therapy 1 (5), 313-342, 2020
|From Simple Mouth Cavities to Complex Oral Mucosal Disorders—Curcuminoids as a Promising Therapeutic Approach|
S Girisa, A Kumar, V Rana, D Parama, UD Daimary, S Warnakulasuriya, ...
ACS pharmacology & translational science 4 (2), 647-665, 2021
|Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer|
S Girisa, S Henamayee, D Parama, V Rana, U Dutta, AB Kunnumakkara
Molecular Biomedicine 2 (1), 1-23, 2021
|Exploring the Cytotoxic Effects of the Extracts and Bioactive Triterpenoids from Dillenia indica against Oral Squamous Cell Carcinoma: A Scientific Interpretation …|
M Aswathy, K Banik, D Parama, P Sasikumar, C Harsha, AG Joseph, ...
ACS Pharmacology & Translational Science 4 (2), 834-847, 2021
|Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review|
E Verma, A Kumar, UD Daimary, D Parama, S Girisa, G Sethi, ...
Journal of Functional Foods 86, 104660, 2021
|Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases|
ABK Aviral Kumar, Choudhary Harsha, Dey Parama, Sosmitha Girisa, Uzni Devi ...
Phytotherapy Research, 2021
|Differential roles of farnesoid X receptor (FXR) in modulating apoptosis in cancer cells.|
S Girisa, V Rana, D Parama, U Dutta, AB Kunnumakkara
Advances in Protein Chemistry and Structural Biology 126, 63-90, 2021
|Oxidative Stress and Inflammation|
V Rana, D Parama, S Girisa, C Harsha, AB Kunnumakkara
Antioxidants and Functional Foods for Neurodegenerative Disorders, 21-36, 2021
|The Promising Potential of Piperlongumine as an Emerging Therapeutics for Cancer|
ABK Dey Parama, Varsha Rana, Sosmitha Girisa, Elika Verma, Uzini Devi ...
Explor Target Antitumor Ther, 2021